Like parthenolide [9] and xanthohumol [31], CalebinA represents a low-toxicity, natural NF-κB inhibitor with promising applications as a therapeutic candidate against gemcitabine-resistant pancreatic cancer. Here, NFKB1 is linked to pancreatic neoplasm.